Saroglitazar Improves Metabolic Profile, Hepatic Steatosis, Inflammation, and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review

被引：0
|
作者：
Duseja, Ajay Kumar [1 ]
De, Arka [1 ]
Mehta, Manu [1 ]
Singh, Priya [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1430
引用
收藏
页码：S1090 / S1090
页数：1
相关论文
共 50 条
  • [1] SAROGLITAZAR MAGNESIUM IMPROVES LIPID PARAMETERS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE / NON-ALCOHOLIC STEATOHEPATITIS
    Parmar, D.
    Gawrieh, S.
    Cusi, K.
    Chalasani, N.
    Cisneros Garza, L. Esthela
    Bihari, C.
    Cruz Lopez, J. L. Pio
    Bainbridge, J.
    Vellanki, R.
    Shaikh, F.
    Jain, P.
    Maroo, S.
    Manjunath, K.
    Parmar, K.
    Patil, K.
    ATHEROSCLEROSIS, 2020, 315 : E47 - E47
  • [2] Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
    Bandyopadhyay, Sanjay
    Samajdar, Shambo Samrat
    Das, Saibal
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [3] Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review
    Mohammadi, Zahra
    Poustchi, Hossein
    Motamed-Gorji, Nazgol
    Eghtesad, Sareh
    Hekmatdoost, Azita
    Saniee, Parastoo
    Merat, Shahin
    ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (01) : 44 - 52
  • [4] Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Dowman, J. K.
    Tomlinson, J. W.
    Newsome, P. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 525 - 540
  • [5] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [6] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [7] Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
    Yilmaz, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (09) : 815 - 823
  • [8] CCN6 improves hepatic steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis
    Song, Yiran
    Li, Chenyang
    Luo, Yuxin
    Guo, Jinbo
    Kang, Yaxing
    Yin, Fengrong
    Ye, Lihong
    Sun, Donglei
    Yu, Jun
    Zhang, Xiaolan
    LIVER INTERNATIONAL, 2023, 43 (02) : 357 - 369
  • [9] Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review
    Yaqub, Sayma
    Ananias, Patricia
    Shah, Arpita
    Luenam, Kanita
    Jose, Arunima Mariya
    Melo, Joao Pedro
    Turkistani, Arifa
    Mohammed, Lubna
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [10] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
12345